A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject

NCT01917357 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Pertussis
Tetanus
Hepatitis B
Haemophilus Infections

Interventions

BIOLOGICAL: Quinvaxem in Uniject
BIOLOGICAL: Quinvaxem in single dose vials

Sponsor

Crucell Holland BV